Robert A. DeLuca
R.Ph., President
Robert DeLuca joined Orexo US, Inc. as President in May, 2013. He has more than 25-years of industry experience at several multinational pharmaceutical companies and brings to Orexo a demonstrated track record of success in the pharmaceutical industry with a combined background in global commercial operations, marketing, market access and sales. He has progressed through senior roles of increasing responsibility at Schering Plough, Berlex, Pharmacia and Sanofi–Aventis. Most recently, Mr. DeLuca held the position of Chief Commercial Officer at Archimedes Pharmaceuticals.
DeLuca is a New Jersey licensed pharmacist and graduated from St. John’s University in New York City. He practiced retail pharmacy for three years post licensure prior to entering the corporate arena. DeLuca also is on the St. John’s College of Pharmacy Advisory Board, serves on the Foundation for Managed Care Pharmacy Board of Trustees, and has memberships in the Academy of Managed Care Pharmacy (AMCP) and in the American Pharmacists Association.
Craig Safran
VP Commercial Operations
Craig Safran joined Orexo US, Inc. in January, 2013 as Vice President, Commercial Operations. He has more than 27 years of industry experience at several multi-national pharmaceutical companies including Sandoz Pharmaceuticals, Purdue Pharma, and Reckitt Benckiser Pharmaceuticals, with experience in, sales, sales leadership and trade/distribution. Mr. Safran graduated from the City University of New York, Queens College with a Bachelor's degree in Physical Education, and from St. Johns University, Tobin School of Business with a Master of Business Administration.
Edward Kim
Chief Medical Officer
Chief Medical Officer since 2022
MBA in Healthcare Management from University of Massachusetts, US, MD from Thomas Jefferson University, US and AB in Biology from Harvard University, US.
Previous experience:
Extensive experience in medical affairs, health economics and outcomes research, and clinical development across multiple senior positions within the pharmaceutical industry. Most recently served as VP and Head of Medical Affairs at Biohaven Pharmaceuticals. Over a decade of experience in clinical practice, academia, and hospital administration as a board-certified psychiatrist.
Does not hold any shares in Orexo. Owns stock options/share awards entitling to 65,600 shares.1